Atropos Health is the developer of the first physician consultation service powered by research-grade real-world data. Using millions of anonymized patient records, Atropos helps providers answer clinical questions that have fallen through the cracks of the evidence-based literature. By leveraging insights from free-text notes and other non-standard data entries that often go overlooked, Atropos empowers more robust research and effective care delivery.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/04/22 | $14,000,000 | Series A |
Boston Millennia Partners Breyer Capital  Emerson Collective | undisclosed |
| 05/23/24 | $33,000,000 | Series B |
Breyer Capital Cencora Ventures Emerson Collective McKesson Ventures Merck Global Health Innovation Fund Presidio Ventures Valtruis | undisclosed |
